🇮🇳IN
Sign In
EM

EMCURE

NSE

Emcure Pharmaceuticals Ltd

₹1,770.40

-12.20(-0.68%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

EMCURE valuation summary

Emcure Pharmaceuticals Ltd trades at 42.8 times trailing earnings. Return on equity is 22.3% and return on capital employed is 23.7%. The dividend yield is 0.19%.

P/E42.8
ROE22.3%
ROCE23.7%
Dividend yield0.19%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer